Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
- PMID: 36269507
- PMCID: PMC9834109
- DOI: 10.1007/s40258-022-00768-3
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
Erratum for
-
Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis.Appl Health Econ Health Policy. 2023 Jan;21(1):141-152. doi: 10.1007/s40258-022-00762-9. Epub 2022 Sep 22. Appl Health Econ Health Policy. 2023. PMID: 36136263 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
